3-D printing in orthopedics is gaining momentum in the production of customized implants, medical devices, and orthotics from diverse materials. 3-D printing technology reduces surgery times, saves money, leads to better stability of the implant in the long run, and improves the clinical outcomes of surgical procedures. 3-D printing applications in orthopedics include:
Introduction to Theranostics
Theranostics is a field of medicine that refers to a combination of diagnostic imaging and therapy to treat various types of cancers. Theranostics = Therapy + Diagnostics. Patients are imaged and depending on the tumour size and spread, are identified for therapy. The therapy is given by localized radiation delivered only to the diseased region, reducing the impact on surrounding healthy cells.
Principle of Theranostics
How does it work?
- Radioactive compound is attached to a linking molecule that is bound to the binding molecule, which attaches to the cancer cell.
This year we’ve witnessed amazing innovations in technology with everything from wearable tech like Google Glass or Nike+ to the recent introduction of Coin, one card that stores all your credit cards, debit cards, personal accounts, business accounts and other cards typically filling your wallet. The healthcare industry was no exception to the rise in disruptive technology changing the way people are impacted. What are some of the most influential healthcare technologies you’ve seen appear this year?
Without a doubt the pace at which new technology is impacting our everyday lives is increasing at lightning speeds. As of today, 29% of Americans say their phone is the first thing and last thing they look at everyday which is a telling sign of how connected we are becoming to technology.
EPFL scientists have developed a tiny, portable personal blood testing laboratory that sends data through mobile phone network. This is a tiny device that can analyse the concentration of these substances in the blood. Implanted just beneath the skin, it can detect up to five proteins and organic acids simultaneously, and then transmit the results directly to a doctor’s computer. This method will allow a much more personalized level of care than traditional blood tests can provide. Health care providers will be better able to monitor patients, particularly those with chronic illness or those undergoing chemotherapy. The prototype, still in the experimental stages, has demonstrated that it can reliably detect several commonly traced substances.
Proteus Digital Health became the first company to receive Food and Drug Administration approval for an ingestible biomedical sensor that monitors the patient’s compliance to medication.
This ‘sensor-enabled tablet’ called Helius comes with an ingestible event marker. It can be administered with pills or incorporated into medicines by the manufacturers. Once swallowed, the sensor is activated by stomach acid. Then, it transmits a signal through the body to the skin patch attached to the skin of a patient, indicating that the patient has ingested medication.